Paul C. Whitesides Jr., M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 75 Emerson Bay Rd, Suite 102, Carolina Shores, NC 28467 Phone: 910-579-8363 Fax: 910-579-8306 |
News Archive
Fewer U.S. high school students are engaging in health risk behaviors compared to their counterparts from 15 years ago, according to the 2005 National Youth Risk Behavior Survey (YRBS), released today by the Centers for Disease Control and Prevention (CDC).
Mary Barnett is one of about a dozen seniors who got a covid vaccine on a recent morning at Neighborhood Health, a clinic tucked in a sprawling public housing development on the south side of downtown Nashville, Tennessee.
22nd Century Group, Inc. today announced that the European Patent Office issued a Notice of Grant to the company for the NBB and A622 genes. Both genes are responsible for nicotine production in the tobacco plant.
Isis Pharmaceuticals, Inc. announced today that it has initiated a study for ISIS-DMPK Rx in patients with Myotonic Dystrophy Type 1 (DM1). DM1 is a rare genetic neuromuscular disease caused by the production of toxic dystrophia myotonica-protein kinase (DMPK) RNA in cells. ISIS-DMPKRx is specifically designed to reduce toxic DMPK RNA.
A generation of children born with HIV are now coming of age and reaching sexual maturity. Girls in this group who are sexually active are experiencing a higher number than expected of cervical abnormalities, a new study finds.
› Verified 9 days ago